Literature DB >> 16622983

Treatment of isolated neuroendocrine liver metastases.

Bryan Clary1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16622983     DOI： 10.1016/j.gassur.2005.08.024

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  15 in total

1.  Resection versus transplantation for liver metastases from neuroendocrine tumors.

Authors:  J Coppa; A Pulvirenti; M Schiavo; R Romito; P Collini; M Di Bartolomeo; A Fabbri; E Regalia; V Mazzaferro
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors.

Authors:  Jens Rosenau; Matthias J Bahr; Reinhard von Wasielewski; Michael Mengel; Hartmut H J Schmidt; Björn Nashan; Hauke Lang; Jürgen Klempnauer; Michael P Manns; Klaus H W Boeker
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

3.  Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.

Authors:  Eren Berber; Nora Flesher; Allan E Siperstein
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

4.  Indications and results of liver transplantation in patients with neuroendocrine tumors.

Authors:  Michael Olausson; Styrbjörn Friman; Christian Cahlin; Ola Nilsson; Svante Jansson; Bo Wängberg; Håkan Ahlman
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

5.  Cryoablation and liver resection for noncolorectal liver metastases.

Authors:  John D Goering; David M Mahvi; John E Niederhuber; Deb Chicks; Layton F Rikkers
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

6.  Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Authors:  Juan M Sarmiento; Glenroy Heywood; Joseph Rubin; Duane M Ilstrup; David M Nagorney; Florencia G Que
Journal:  J Am Coll Surg       Date:  2003-07       Impact factor: 6.113

7.  Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Authors:  Jeffrey A Norton; Maryann Kivlen; Michelle Li; Darren Schneider; Timothy Chuter; Robert T Jensen
Journal:  Arch Surg       Date:  2003-08

8.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

9.  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

Authors:  William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

Authors:  H Chen; J M Hardacre; A Uzar; J L Cameron; M A Choti
Journal:  J Am Coll Surg       Date:  1998-07       Impact factor: 6.113
View more
  2 in total

1.  Surgical treatment of neuroendocrine liver metastases.

Authors:  Ser Yee Lee; Peng Chung Cheow; Jin Yao Teo; London L P J Ooi
Journal:  Int J Hepatol       Date:  2012-01-26

2.  Surgical treatment of liver metastases in neuroendocrine neoplasms.

Authors:  Palepu Jagannath; Deepak Chhabra; Shailesh Shrikhande; Rajiv Shah
Journal:  Int J Hepatol       Date:  2012-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.